Monday, April 28, 2025

Latest

Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq Capital Market on Tuesday. The initial public offering is estimated to gross US$6 million.

The offering consists of 1.0 million common shares, initially set at 3.0 million, selling at US$6.00 per share. The company is set to trade on the Nasdaq market under the symbol “HPCO”.

Boustead Securities acts as the sole bookrunner for the said offering, which is slated to close on September 1, 2022, subject to customary closing conditions.

The California-based firm makes CBD and hemp-based cigarettes, offering smokers a non-nicotine and tobacco alternative. The company aims to take on the US$1 trillion tobacco industry with its portfolio, including its own The Real Stuff functional hemp cigarette and rolling paper brand.


Information for this briefing was found via Edgar, Investment U, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Electric Vehicle Maker Rivian Prices Upsized US$11.9 Billion IPO

Start-up electric vehicle maker Rivian Automotive, Inc. (Nasdaq: RIVN) started trading on the Nasdaq Global...

Wednesday, November 10, 2021, 02:17:00 PM

Fintech Firm-Backed SPAC FTAC Emerald Acquisition Prices US$220 Million IPO

Special purpose acquisition company FTAC Emerald Acquisition Corp. (Nasdaq: EMLDU) started trading publicly on the...

Thursday, December 16, 2021, 02:22:00 PM

Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it...

Wednesday, June 22, 2022, 02:14:00 PM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Pet Valu Closes IPO Issuing 15.8 Million Shares, Raises $316.3 Million

Pet Valu Holdings Ltd. (TSX: PET) closed its initial public offering today, raising gross proceeds...

Wednesday, June 30, 2021, 11:39:00 AM